Literature DB >> 14728933

Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients.

P B Ottevanger1, P H M De Mulder, R P T M Grol, H van Lier, L V A M Beex.   

Abstract

Guidelines are tools to improve the quality of care in daily practice. To accomplish adherence, active implementation is needed. The effect of audit, group-oriented feedback and educational activities to increase guideline adherence were investigated in this study. Treatment according to a guideline for premenopausal node-positive breast cancer patients from 1988 to 1992 (P1) and from 1996 to 1998 (P2) was assessed using the following indicators: percentage of patients with breast-conserving surgery, secondary surgery, > or = 10 reported resected axillary lymph nodes, reported tumour differentiation grade, reported hormonal receptor status, chemotherapy received (CT), start of CT < or = 28 days after surgery, Dose Intensity (DI) > or = 85% and completion of CT < or = 1 week beyond the ideal duration of CT. Data were audited from patients' records. The first audit resulted in a quality programme with feedback focused on the delivery of chemotherapy and resected axillary lymph nodes and educational sessions. A Fisher's exact test was used to estimate significant differences between the two time periods. In P1, 323 patients and in P2, 155 patients were eligible for treatment according to the guideline. The percentage of patients with > or = 10 lymph nodes improved from 65.3 to 81.3% (P=0.0004), as did the percentage with a reported oestrogen receptor (ER) status, from 84.8 to 96.8% (P=0.00004), progesterone receptor (PR) status from 82.3% to 97.4% (P<0.000001) and with a DI > or = 85%, from 74.9 to 93.9% (P=0.000003). Adherence varied between the hospitals. In conclusion, significant improvements were observed for the indicators of resected axillary lymph nodes and DI of chemotherapy, which may be attributed to the quality programme. Repeated assessment of the adherence to the guideline is important to observe changes and interhospital variations in order to remain focused on areas for improvement.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14728933     DOI: 10.1016/s0959-8049(03)00660-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

1.  Guideline-compatible treatment of breast cancer patients: the status quo in schleswig-holstein.

Authors:  Annika Waldmann; Ron Pritzkuleit; Heiner Raspe; Alexander Katalinic
Journal:  Dtsch Arztebl Int       Date:  2008-05-02       Impact factor: 5.594

2.  Introduction of a breast cancer care programme including ultra short hospital stay in 4 early adopter centres: framework for an implementation study.

Authors:  Mascha de Kok; Caroline N A Frotscher; Trudy van der Weijden; Alfons G H Kessels; Carmen D Dirksen; Cornelis J H van de Velde; Jan A Roukema; Antoine V R J Bell; Fred W van der Ent; Maarten F von Meyenfeldt
Journal:  BMC Cancer       Date:  2007-07-02       Impact factor: 4.430

3.  Healthcare providers' adherence to breast cancer guidelines in Europe: a systematic literature review.

Authors:  Ena Niño de Guzmán; Yang Song; Pablo Alonso-Coello; Carlos Canelo-Aybar; Luciana Neamtiu; Elena Parmelli; Javier Pérez-Bracchiglione; Montserrat Rabassa; David Rigau; Zuleika Saz Parkinson; Iván Solà; Adrián Vásquez-Mejía; Ignacio Ricci-Cabello
Journal:  Breast Cancer Res Treat       Date:  2020-05-06       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.